Clinical Trials

Clinical Trial Detail

Return to search results.

A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma in Situ Resected by Lumpectomy

Research Study Number       NSABP B-43
Principal Investigator       Tanya Wahl, MD
Phase       III

Look up trial at NIH

Research Study Number       NSABP B-43
Contact       Nancy Knudsen, RN
Telephone       206/667-4692

Breast Cancer; Solid Tumors

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials

Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.